Government committed to facilitate easy financing for private sector: Finance Minister    Egyptian, Chinese transport officials discuss bilateral cooperation    Health Ministry adopts rapid measures to implement comprehensive health insurance: Abdel Ghaffar    Rafah crossing closure: Over 11k injured await vital treatment amidst humanitarian crisis in Gaza    Nouran Gohar, Diego Elias win at CIB World Squash Championship    Coppola's 'Megalopolis': A 40-Year Dream Unveiled at Cannes    World Bank assesses Cairo's major waste management project    Egypt sets EGP 4b investment plan for Qena governorate    Russian refinery halts operations amid attacks    NBE, CIB receive awards at EBRD Annual Meetings    Egypt's gold prices increase on Sunday    Partnership between HDB, Baheya Foundation: Commitment to empowering women    China's pickup truck sales rise 4.4% in April    Venezuela's Maduro imposes 9% tax for pensions    Health Minister emphasises state's commitment to developing nursing sector    20 Israeli soldiers killed in resistance operations: Hamas spokesperson    Sudan aid talks stall as army, SPLM-N clash over scope    Microsoft eyes relocation for China-based AI staff    K-Movement Culture Week: Decade of Korean cultural exchange in Egypt celebrated with dance, music, and art    Empower Her Art Forum 2024: Bridging creative minds at National Museum of Egyptian Civilization    Niger restricts Benin's cargo transport through togo amidst tensions    Egyptian consortium nears completion of Tanzania's Julius Nyerere hydropower project    Sweilam highlights Egypt's water needs, cooperation efforts during Baghdad Conference    AstraZeneca injects $50m in Egypt over four years    Egypt, AstraZeneca sign liver cancer MoU    Swiss freeze on Russian assets dwindles to $6.36b in '23    Prime Minister Madbouly reviews cooperation with South Sudan    Egypt retains top spot in CFA's MENA Research Challenge    Egyptian public, private sectors off on Apr 25 marking Sinai Liberation    Debt swaps could unlock $100b for climate action    Amal Al Ghad Magazine congratulates President Sisi on new office term    Financial literacy becomes extremely important – EGX official    Euro area annual inflation up to 2.9% – Eurostat    BYD، Brazil's Sigma Lithium JV likely    UNESCO celebrates World Arabic Language Day    Motaz Azaiza mural in Manchester tribute to Palestinian journalists    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



National immunity
Published in Ahram Online on 22 - 06 - 2021

The Egyptian pharmaceutical company Pharco will begin production of the Russian COVID-19 vaccine Sputnik V before the end of the year. Egypt is also due to begin manufacturing the Chinese Sinovac vaccine locally and is in talks to manufacture the British AstraZeneca vaccine. Research is also ongoing to develop an Egyptian vaccine.
According to a press release by the Ministry of Health and Population, three million vaccine doses will be manufactured daily in a new complex owned by the Holding Company for Biological Products and Vaccines (VACSERA). Established at a total cost of around $33 million, the complex, the largest plant for vaccine production in the Middle East and Africa, includes eight laboratories and the capacity to store 150 million doses at optimum temperatures.
Ministry of Health Spokesman Khaled Megahed says the VACSERA complex is expected to produce 40 million doses of the Chinese vaccine this year, with the first two million expected to be available within a month.
Around two million people have been vaccinated since February, and a further 3.5 million have registered for the jab. The number of vaccine centres has been increased to 400 nationwide to cater for the increased demand for vaccination.
Megahed said Egypt is first aiming for self-sufficiency in vaccine production, after which it will begin to export vaccines to Arab and African countries.
"We do not want to depend on a single source to supply us with vaccines, and we intend to vaccinate at least 70 per cent of the population as soon as possible," said Megahed.
Chest diseases consultant and member of the Egyptian Society of Allergy and Immunology Magdy Badran says importing vaccines "is an expensive process, and in some cases may be subject to political whims, thus threatening the availability of the required quantities".
"Providing large quantities of them in Egypt will reduce the spread of the virus gradually, until we reach the stage of herd immunity, and this could happen within the coming few months."
Vaccines stimulate the immune response to the COVID-19 virus, providing vaccinated individuals with protection from severe complications and reducing the possibility of transmission.
"All the vaccines recognised by the WHO so far are effective in protecting against critical conditions in case of COVID-19 infection," says Badran. "It is possible that we will need to vaccinate citizens annually with booster doses if COVID-19 turns into a seasonal, endemic, or changeable virus."
Badran advises people to continue to apply precautionary measures even when vaccinated.


*A version of this article appears in print in the 24 June, 2021 edition of Al-Ahram Weekly


Clic here to read the story from its source.